Crossmark

YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo

Published Online: 2016-04-23

Published Print: 2016-06

Authors

Cai, De

Qiu, Zhiqing

Yao, Weimin

Liu, Yuyu

Huang, Haixiang

Liao, Sihai

Luo, Qun

Xie, Liming

Lin, Zhixiu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (2014A01021, 2015A01025, 2014KTSCX084, 81273518)
License Information

Text and Data Mining valid from 2016-04-23

Document is current